cas 2248003-60-1|| where to buy N-[4-[[5-fluoro-7-(2-methoxyethoxy)-4-quinazolinyl]amino]phenyl]-4-(1-methylethyl)-1H-1,2,3-triazole-1-acetamide

Nombre del producto:N-[4-[[5-fluoro-7-(2-methoxyethoxy)-4-quinazolinyl]amino]phenyl]-4-(1-methylethyl)-1H-1,2,3-triazole-1-acetamide

IUPAC Name:N-(4-{[5-fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1H-1,2,3-triazol-1-yl]acetamide

Unidad de embalaje	Stock disponible	Precio($)
CM456311-10mg	4-5 Weeks	Ǻƅŭ
CM456311-50mg	6-7 Weeks	ƻșșş
CM456311-100mg	7-8 Weeks	ŭƅǺň

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2248003-60-1 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :2248003-60-1; Fórmula molecular:C24H26FN7O3; Punto de fusión:-; Código de sonrisas:COCCOC1=CC2=NC=NC(NC3=CC=C(NC(=O)CN4C=C(N=N4)C(C)C)C=C3)=C2C(F)=C1; Densidad:

: Número de catálogo:CM456311; Peso molecular:479.52; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Quinazolines; Quinazolines belong to heterocyclic chemistry, also known as 1,3-naphthalenes. The backbone consists of two six-membered aromatic rings fused to each other, with two nitrogen atoms at positions 1 and 3 on the backbone. The presence of these two nitrogen atoms in quinazoline increases its importance in pharmaceutical and biological reactions. Quinazolines and their derivatives are among the most important heterocyclic compounds due to their diverse chemical reactivity and important range of biological activities.

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.